The present invention relates to a method of analyzing methylation status of a CpG site in a promoter region of at least one gene selected from ACTG1, EPHA4 and TSC22D1 in DNA extracted from a biological sample and determining the presence or absence of a cancer cell derived from hepatocellular carcinoma based on the analysis result. The present invention also relates to a determination marker and kit used for the method.